Hrt Financial LP Hepion Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.14 - $1.58 $39,966 - $55,391	-35,058 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.39 - $2.1 $34,192 - $51,657	24,599 Added 235.19%	35,058 $53,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $2.26 $16,316 - $23,637	10,459 New	10,459 $20,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $49.5M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.